Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-10-22

Clinical Trial Update: Treatment of Patients With Nocturia (Non-PK Study) [Phase 3]

View source ↗

Summary

Phase 3 trial update for treatment of nocturia; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Serenity Pharmaceuticals, Inc. | Conditions: Nocturia | Phase 3 | Status: COMPLETED | Results posted: 2020-10-22